Perioperative Versus Adjuvant Systemic Therapy in Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG
Contact:
NCT Number:
Protocol:
ACYY1937
Study Status:
Active/Enrolling
Population:
Adult
Phase:
III
The purpose of this study is to compare two usual treatment approaches using approved drugs before and after surgery or only after the surgery to find out which approach is better. The study doctors will decide which approach is better by determining which study group was less likely to have their lung cancer grow or spread.
Are you Eligible? (Inclusion Criteria)
- Are you 18 years of age or older? - Have you been diagnosed with early-stage Non-Small Cell Lung Cancer, which your doctor thinks can be treated with surgery? - Are you able to come to clinic for regularly scheduled treatment and assessment?
Specialty Area(s)
Lung cancer
